- $4.02bn
- $3.91bn
- $795.31m
- 97
- 14
- 42
- 49
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 16.21 | ||
| Price to Tang. Book | 19.12 | ||
| Price to Free Cashflow | 57.36 | ||
| Price to Sales | 5.05 | ||
| EV to EBITDA | 32.22 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 35.2% | ||
| Return on Equity | 33.9% | ||
| Operating Margin | 11.96% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 592.23 | 552.64 | 646.23 | 718.56 | 795.31 | n/a | n/a | 5.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +4.92 | +0.19 | +43.57 | +2.97 | +16.52 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CorVel Corporation applies technology including artificial intelligence, machine learning and natural language processing to enhance the management of episodes of care and the related health care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies in managing workers' compensation and health, auto and liability services. Its customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients. The Company's services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. The Company offers a complete medical savings solution for all in-network and out-of-network medical bills. Its bill review services include coding review and re-bundling, reasonable and customary review, fee schedule analysis, preferred provider organization management, and repricing.
Directors
- V. Gordon Clemons CHM (77)
- Michael Combs PRE (57)
- Brandon O'Brien CFO (41)
- Maxim Shishin CIO (46)
- Diane Blaha CMO (66)
- Lori Landon VPR
- Joseph Rupp VPR
- Jennifer Yoss VPR (43)
- Richard Schweppe SEC (65)
- R. Judd Jessup LED (73)
- Steven Hamerslag IND (64)
- Alan Hoops IND (73)
- Jean Macino IND (78)
- Jeffrey Michael IND (64)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- May 16th, 1991
- Public Since
- June 28th, 1991
- No. of Shareholders
- 693
- No. of Employees
- 4,870
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 17,121,778
- Address
- SUITE 1020, 2010 MAIN STREE, IRVINE, 92614
- Web
- https://www.corvel.com/
- Phone
- +1 9498511473
- Auditors
- Haskell & White LLP
Upcoming Events for CRVL
CorVel Corp Annual Shareholders Meeting
Q2 2025 CorVel Corp Earnings Release
Similar to CRVL
Acadia Healthcare
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
FAQ
What is the CorVel share price?
As of Today at 20:07 UTC, shares in CorVel are trading at $234.50. This share price information is delayed by 15 minutes.
How has the CorVel share price performed this year?
Shares in CorVel last closed at $234.50 and the price had moved by +15.02% over the past 365 days. In terms of relative price strength the CorVel share price has underperformed the S&P500 Index by -7.52% over the past year.
What are the analyst and broker recommendations for CorVel?
There is no consensus recommendation for this security.
What is the CorVel dividend yield?
CorVel does not currently pay a dividend.
Does CorVel pay a dividend?
CorVel does not currently pay a dividend.
When does CorVel next pay dividends?
CorVel does not currently pay a dividend.
How do I buy CorVel shares?
To buy shares in CorVel you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CorVel?
As of the previous close price of $234.50, shares in CorVel had a market capitalisation of $4.02bn.
Where are CorVel shares listed?
Here are the trading details for CorVel:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: CRVL
What kind of share is CorVel?
Based on an overall assessment of its quality, value and momentum CorVel is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CorVel share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the CorVel share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CorVel. Over the past six months, its share price has underperformed the S&P500 Index by -9.67%.
As of the last closing price of $234.50, shares in CorVel were trading +2.47% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CorVel PE Ratio?
The CorVel PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $234.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CorVel?
CorVel's management team is headed by:
- V. Gordon Clemons - CHM
- Michael Combs - PRE
- Brandon O'Brien - CFO
- Maxim Shishin - CIO
- Diane Blaha - CMO
- Lori Landon - VPR
- Joseph Rupp - VPR
- Jennifer Yoss - VPR
- Richard Schweppe - SEC
- R. Judd Jessup - LED
- Steven Hamerslag - IND
- Alan Hoops - IND
- Jean Macino - IND
- Jeffrey Michael - IND